Pilot Study of the Effects of LY2409021 in Patients With Type 1 Diabetes Mellitus
Phase of Trial: Phase I
Latest Information Update: 17 Jun 2014
At a glance
- Drugs Adomeglivant (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics
- 25 Jun 2013 Results presented at the 73rd Annual Scientific Sessions of the American Diabetes Association.
- 01 Sep 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 26 Jul 2012 Actual initiation date (July 2012) and location (USA) added as reported by ClinicalTrials.gov.